The export volumes were lower , Teva they have given incremental revenue guidance of 600 Cr for FY 25 . FY 24 revenue contribution was 50 Cr. The margin pressure is bcoz of some seasonality of products which would have to be dug in further , unfavorable forex - I don’t buy this , rupee has been stable despite good Q3 they said PAT is flat QoQ bcoz of some mark to mark losses but this time around rupee has been stable . Further higher employee cost bcoz of new hiring for new capacity . Let’s see what they have to say further about the result in con call.
Subscribe To Our Free Newsletter |